Assis Alessandra Faccin
Known title: SVP and GM, Life SciencesCIK: 0001931500
Assis Alessandra Faccin's purchase track record
Assis Alessandra Faccin has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 1/31/2025 | ASH | $202K | -21.6% | -19.3% | +3.3% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| ASH | ▲ Buy | Option Exercise | 3,215 | $213K | 7/27/2026 | View on chart |
| ASH | ▼ Sell | Tax Withholding | 884 | $59K | 7/27/2026 | View on chart |
| ASH | ▲ Buy | Option Exercise | 1,340 | $71K | 11/13/2025 | View on chart |
| ASH | ▼ Sell | Tax Withholding | 570 | $30K | 11/13/2025 | View on chart |
| ASH | ▲ Buy | Option Exercise | 3,123 | $160K | 7/25/2025 | View on chart |
| ASH | ▼ Sell | Tax Withholding | 1,327 | $68K | 7/25/2025 | View on chart |
| ASH | ▲ Buy | Open Market | 3,150 | $202K | 1/31/2025 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
ASH: UBS lowers price target to $80
UBS kept its rating unchanged on Ashland Inc. and reduced its price target to $80. The new target is close to the average analyst consensus of $80.18 and sits near the top of the stock’s 52‑week range. With a trailing P/E of 62 and a dividend yield of 1.94%, the adjustment reflects expectations for future earnings growth.
ASH: UBS lowers price target to $80. UBS kept its rating unchanged on Ashland Inc. and reduced its price target to $80. The new target is close to the average analyst consensus of $80.18 and sits near the top of the stock’s 52‑week range. With a trailing P/E of 62 and a dividend yield of 1.94%, the adjustment reflects expectations for future earnings growth.